FDA 批准 抗凝药 vorapaxar?May 8, 2014 -- The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart attack or blockages in the arteries to the legs.查看更多14个回答 . 15人已关注